Intrepid Banker Insights

OCTOBER 17, 2022

We ended 2021 having survived another year of the pandemic, with equity markets at or near all-time highs, interest rates near historic lows, and technology M&A activity at record levels. As public market valuations fell, SPACs evaporated and other buyers began to reevaluate the need to pay nose-bleed multiples.

Valuation 52

Valuation M&A Capital Middle Market 52

How2Exit

DECEMBER 11, 2023

The company ensures that sellers understand the proper valuation of their businesses and helps them navigate the financing process. 2021, March 10). ." - Devin Craig rn Peterson Acquisitions takes a proactive approach to the sell-side process, guiding sellers through every step and managing their expectations. In How to Exit Podcast.

Acquisitions 130

Acquisitions Mergers and Acquisitions Business Education 130

Sica Fletcher

APRIL 2, 2024

Insurance M&A Deal Valuation, 2024 Starting out in 2024, EBITDA and revenue multiples are in a good place, experiencing modest YoY growth despite the economic downturn of the last 18 months. Granted, these numbers are not quite at pre-pandemic levels yet (although they are close), and they are nowhere near the M&A boom of 2021.

M&A 52

M&A Insurance S&P Broker 52

Sica Fletcher

JUNE 20, 2024

Conversely, when interest rates are high, valuations are supposed to decrease because buyers will try to make up what they are losing to interest. Deal Volume Has Lowered Deal volume has never quite recovered from the near-record numbers posted in 2021. for insurance agencies. for insurance agencies.

M&A 52

M&A Insurance Valuation Equities 52

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Sica Fletcher

JULY 23, 2024

Possible Changes in Tax Law May Drive Transactions H2 2021 specifically saw a small surge in deal volume because of expected increases to the laws surrounding capital gains taxes. This means that they often lack the specialized industry knowledge to effectively negotiate your deal. Are you meeting the firm’s principals?

M&A 52

M&A Insurance S&P Valuation 52

Cooley M&A

JULY 9, 2021

May 13, 2021), may provide new fodder for appraisal arbitrage. May 2021) +2.61% Yes, reduced for synergies and increased for changes in value between signing and closing (due to passage of Tax Act) Arms-length transaction with third party; open and active post-signing market check; unconflicted board Final (no appeal).

Mergers and Acquisitions 52

Mergers and Acquisitions Sale Shares Entertainment 52

Cleary M&A and Corporate Governance Watch

MAY 10, 2023

Stockholders Litigation , has potentially significant implications for corporations and their boards in the negotiation of investment agreements with significant stockholders. In an opinion by Vice Chancellor Zurn, the Court held that Corwin cleansing does not apply to claims for post-closing injunctive relief under Unocal.

Mergers and Acquisitions 52

Mergers and Acquisitions Stock IT Acquisitions 52

Cooley M&A

JANUARY 20, 2022

Despite everyone’s efforts in 2021, including the rollout of vaccines and varying rounds of lockdowns and work-from-home mandates, a true “return to normal” for M&A dealmakers was foiled anew by COVID-19 and its variants. trillion during 2021 – an increase of 71% compared to 2020 – and accounted for 20% of the $5.9 trillion(!)

M&A 40

M&A Insurance Mergers and Acquisitions IPO 40

Cooley M&A

JANUARY 25, 2024

The higher interest rates escalated borrowing expenses, making mega-deals (deals valued at $5 billion or more) significantly more expensive, due to their heavy reliance on debt financing, and impacted valuation multiples with higher discount rates.

M&A 52

M&A Mergers and Acquisitions Investment Government 52

Cooley M&A

JANUARY 20, 2022

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 driven assets. term average of approximately 35%.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Sica Fletcher

OCTOBER 29, 2024

For a more thorough breakdown of RIA valuations, see our “How to Value an RIA.” Valuation: Your M&A advisor or a third-party agency reviews the provided documentation to determine the overall value of the business. Valuation is typically not something that sellers do themselves. Multiple of What?

Valuation 52

Valuation M&A Business Negotiation 52

Cooley M&A

FEBRUARY 3, 2025

The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. billion acquisition of Altair, IBMs pending $6.4 So is tech M&A back?

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59